Mode
Text Size
Log in / Sign up
N/A N=95 Randomized Single-blind Prevention

Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents

Adolescent Drinking · HIV/AIDS · Drug Use

Enrolled (actual)
95
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcome: Primary: Percentage of Participants Completing the Study at 6 Months — 44; 46 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Economic Empowerment Intervention (Behavioral); Alcohol and Drug Use Risk Reduction Sessions (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Washington University School of Medicine
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Completing the Study at 6 Months
44; 46
PRIMARY
Number of Participants Enrolling in the Study at Baseline
44; 46
SECONDARY
Percentage of Participants That Self-reported Use of Any Drug in the Last 3 Months at the Baseline Assessment
25; 31
SECONDARY
Percentage of Participants That Self-reported Use of Any Drug in Last 3 Months at the 6-month Assessment
21; 24
SECONDARY
Optimism Scale Total Score at Baseline
38.5; 38.8
SECONDARY
Optimism Scale Total Score at 6 Months
39.5; 39.3
SECONDARY
Beck Hopelessness Scale Total Score at Baseline
4.6; 5.2
SECONDARY
Beck Hopelessness Scale Total Score at 6 Months
5.2; 4.4
SECONDARY
Depressive Symptoms Total Score at Baseline
38.1; 37.6
SECONDARY
Depressive Symptom Total Score at 6 Months
37.6; 37.1
SECONDARY
Percentage of Participants That Self-reported Use of Any Drug in Last 12 Months at the Baseline Assessment
34; 39
SECONDARY
Percentage of Participants That Self-reported Use of Any Drug in Last 12 Months at 6 Month Assessment
32; 28
SECONDARY
Percentage of Participants That Self-reported Use of Alcohol in Last 12 Months at Baseline
31; 35
SECONDARY
Percentage of Participants That Self-reported Use of Alcohol in Last 12 Months at the 6-month Assessment
29; 26
SECONDARY
Percentage of Participants With a Positive Urine Test for Any Drug at Baseline
15; 24
SECONDARY
Percentage of Participants With a Positive Urine Test for Any Drug at the 6-month Assessment
11; 15
SECONDARY
Percentage of Participants With a Positive Urine Test for Alcohol at the Baseline Assessment
8; 20
SECONDARY
Percentage of Participants With a Positive Urine Test for Alcohol at the 6-month Assessment
8; 12

Summary

The proposed study will test the impact of an economic empowerment intervention on reducing alcohol and drug use (ADU) among adolescents and youth living with HIV (AYLHIV) in poverty-impacted communities in Uganda. It focuses on improving understanding of multi-level context- specific risk and protective factors for ADU among AYLHIV.

Eligibility Criteria

Inclusion Criteria for AYLHIV:

  • male or female AYLHIV aged 15-24 years;
  • medically diagnosed with HIV and aware of their HIV status;
  • enrolled in care at one of the selected HIV clinics.
  • positive self-report or urine test for alcohol or drug use

Exclusion Criteria

  • any AYLHIV with negative urine alcohol or drug use test and negative self-report for alcohol and drug use
  • anyone with a significant cognitive impairment that interferes with their understanding of the informed consent process, or is unable/unwilling to consent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05597865). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search